End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities

Abstract

Pulmonary arterial hypertension (PAH) is a progressive, incurable disease that results in significant symptom burden, health care utilization, and eventually premature death. Despite the advancements made in treatment and management strategies, survival has remained poor. End-of-life care is a challenging issue in management of PAH, especially when patients are in younger age group. End-of-life care revolves around symptom palliation and reducing psychosocial disease burden for a dying patient and entails advanced care planning that are often challenging. Thus, support from palliative care specialist becomes extremely important in these patients. Early introduction to palliative care in patients with high symptom burden and psychosocial suffering is suggested. Despite of the benefits of an early intervention, palliative care remains underutilized in patients with PAH, and this significantly raises issues around end-of-life care in PAH. In this review, we will discuss the opportunities offered and the existing barriers in addressing high symptom burden and end-of-life care issues. We will focus on the current evidence, identify areas for future research, and provide a call-to-action for better guidance to PAH specialists in making timely, appropriate interventions that can help mitigate end-of-life care issues.

Keywords

pulmonary arterial hypertension - palliative care - end-of-life - utilization - barriers

Publikationsverlauf

Artikel online veröffentlicht:
17. Juli 2023

• References

• 1 Benza RL, Gomberg-Maitland M, Elliott CG. et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest 2019; 156 (02) 323-337
• 2 Humbert M, Kovacs G, Hoeper MM. et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43 (38) 3618-3731
• 3 Halimi L, Suehs CM, Marin G. et al. Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study. ERJ Open Res 2021; 7 (03) 00617-2020
• 4 Olsson KM, Meltendorf T, Fuge J. et al. Prevalence of mental disorders and impact on quality of life in patients with pulmonary arterial hypertension. Front Psychiatry 2021; 12 (May): 667602
• 5 Rawlings GH, Thompson AR, Armstrong I, Novakova B, Beail N. Coping styles associated with depression, health anxiety and health-related quality of life in pulmonary hypertension: cross-sectional analysis. BMJ Open 2022; 12 (08) e062564
• 6 Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35 (05) 1079-1087
• 7 Chang KY, Duval S, Badesch DB. et al; PHAR Investigators*. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc 2022; 11 (09) e024969
• 8 Chiang YC, Hu LY, Couper J. et al. Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study. Pulm Circ 2018; 8 (03) 2045894018787479
• 9 Caldarone F, Gebhardt P, Hoeper MM. et al. Metacognitions in patients with frequent mental disorders after diagnosis of pulmonary arterial hypertension. Front Psychiatry 2022; 13 (April): 812812
• 10 Christiansen D, Porter S, Hurlburt L, Weiss A, Granton J, Wentlandt K. Pulmonary arterial hypertension: a palliative medicine review of the disease, its therapies, and drug interactions. J Pain Symptom Manage 2020; 59 (04) 932-943
• 11 Anand V, Vallabhajosyula S, Cheungpasitporn W. et al. Inpatient palliative care use in patients with pulmonary arterial hypertension: temporal trends, predictors, and outcomes. Chest 2020; 158 (06) 2568-2578
• 12 Ferrell BR, Twaddle ML, Melnick A, Meier DE. National consensus project clinical practice guidelines for quality palliative care guidelines. J Palliat Med 2018; 21 (12) 1684-1689
• 13 Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ 2005; 330 (7498): 1007-1011
• 14 Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003; 289 (18) 2387-2392
• 15 Galiè N, Humbert M, Vachiery JL. et al; ESC Scientific Document Group. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37 (01) 67-119
• 16 Fenstad ER, Shanafelt TD, Sloan JA. et al. Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey. Pulm Circ 2014; 4 (03) 504-510
• 17 Sahay S, Balasubramanian V, Memon H. et al. Utilization of risk assessment tools in management of PAH: a PAH provider survey. Pulm Circ 2022; 12 (02) e12057
• 18 Rohlfing AB, Bischoff KE, Kolaitis NA. et al. Palliative care referrals in patients with pulmonary arterial hypertension: the Pulmonary Hypertension Association Registry. Respir Med 2023; 206: 107066
• 19 Wilson M, Anguiano RH, Awdish RLA. et al. An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension. Pulm Circ 2022; 12 (01) e12003
• 20 Vallabhajosyula S, Prasad A, Dunlay SM. et al. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc 2019; 8 (15) e011954
• 21 Alqahtani F, Balla S, Almustafa A, Sokos G, Alkhouli M. Utilization of palliative care in patients hospitalized with heart failure: a contemporary national perspective. Clin Cardiol 2019; 42 (01) 136-142
• 22 Rush B, Hertz P, Bond A, McDermid RC, Celi LA. Use of palliative care in patients with end-stage COPD and receiving home oxygen: national trends and barriers to care in the United States. Chest 2017; 151 (01) 41-46
• 23 Mulvey CL, Smith TJ, Gourin CG. Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer. Head Neck 2016; 38 (03) 355-363
• 24 Loh KP, Abdallah M, Shieh MS. et al. Use of inpatient palliative care services in patients with advanced cancer receiving critical care therapies. J Natl Compr Canc Netw 2018; 16 (09) 1055-1064
• 25 Schoenherr LA, Bischoff KE, Marks AK, O'Riordan DL, Pantilat SZ. Trends in hospital-based specialty palliative care in the United States from 2013 to 2017. JAMA Netw Open 2019; 2 (12) e1917043
• 26 Hoeper MM, Galié N, Murali S. et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165 (03) 341-344
• 27 Yang JZ, Odish MF, Mathers H. et al. Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Pulm Circ 2022; 12 (02) e12066
• 28 Tonelli AR, Arelli V, Minai OA. et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med 2013; 188 (03) 365-369
• 29 Cardenas V, Rahman A, Zhu Y, Enguidanos S. Reluctance to accept palliative care and recommendations for improvement: findings from semi-structured interviews with patients and caregivers. Am J Hosp Palliat Care 2022; 39 (02) 189-195
• 30 Brown CE, Steiner JM, Leary PJ, Curtis JR, Engelberg RA. A world of maximalist medicine: physician perspectives on palliative care and end-of-life for patients with pulmonary arterial hypertension. J Pain Symptom Manage 2023; 65 (04) e329-e335
• 31 Grinnan DC, Swetz KM, Pinson J, Fairman P, Lyckholm LJ, Smith T. The end-of-life experience for a cohort of patients with pulmonary arterial hypertension. J Palliat Med 2012; 15 (10) 1065-1070
• 32 Swetz KM, Shanafelt TD, Drozdowicz LB. et al. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. J Heart Lung Transplant 2012; 31 (10) 1102-1108
• 33 Hrustanovic-Kadic M, Ziegler C, El-Kersh K. Palliative care perception in pulmonary arterial hypertension: evaluating the interaction of PPCI, PAH-SYMPACT questionnaire, and the reveal 2.0 risk score. Ann Am Thorac Soc 2021; 18 (02) 361-364
• 34 Nelson KE, Wright R, Peeler A, Brockie T, Davidson PM. Sociodemographic disparities in access to hospice and palliative care: an integrative review. Am J Hosp Palliat Care 2021; 38 (11) 1378-1390
• 35 Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med 2013; 16 (11) 1329-1334
• 36 Ivey GD, Johnston FM. Barriers to equitable palliative care utilization among patients with cancer. Surg Oncol Clin N Am 2022; 31 (01) 9-20
• 37 Enguidanos S, Lomeli S, Kogan AC, Rahman A, Lewis N. Home-based palliative care team perspectives on challenges in patient referral and enrollment. J Pain Symptom Manage 2022; 63 (05) 665-672
• 38 Khirfan G, Tonelli AR, Ramsey J, Sahay S. Palliative care in pulmonary arterial hypertension: an underutilised treatment. Eur Respir Rev 2018; 27 (150) 180069
• 39 Gu S, Hu H, Dong H. Systematic review of health-related quality of life in patients with pulmonary arterial hypertension. PharmacoEconomics 2016; 34 (08) 751-770
• 40 Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev 2015; 24 (138) 621-629
• 41 Chiu JS, Zuckerman WA, Turner ME. et al. Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes. J Heart Lung Transplant 2015; 34 (03) 376-380
• 42 Sandoval J, Gaspar J, Peña H. et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J 2011; 38 (06) 1343-1348
• 43 Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv 2017; 90 (07) 1145-1153
• 44 Chen SL, Zhang FF, Xu J. et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol 2013; 62 (12) 1092-1100
• 45 Zhang H, Wei Y, Zhang C. et al. Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized PADN-CFDA trial. JACC Cardiovasc Interv 2022; 15 (23) 2412-2423
• 46 Bobhate P, Mohanty SR, Tailor K. et al. Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension. Indian Heart J 2021; 73 (02) 196-204
• 47 Kim SH, Jang WS, Lim HG, Kim YJ. Potts shunt in patients with primary pulmonary hypertension. Korean J Thorac Cardiovasc Surg 2015; 48 (01) 52-54
• 48 Said SM. Commentary: Right ventricular unloading with valved conduit for end-stage pulmonary arterial hypertension: when Eisenmenger is the last hurrah. J Thorac Cardiovasc Surg 2021; 161 (04) 1447-1448
• 49 Goldar G, Chaisson N, Ghobrial J. Transcatheter valve implantation in reversed Potts shunt in pulmonary arterial hypertension: keeping the shunt reversed. JACC Case Rep 2022; 4 (24) 101678
• 50 Vanhoof M J, Delcroix M, Vandevelde E. et al. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J Heart Lung Transplant 2014; 33 (08) 800-808
• 51 Pfeuffer E, Krannich H, Halank M. et al. Anxiety, depression, and health-related QOL in patients diagnosed with PAH or CTEPH. Lung 2017; 195 (06) 759-768
• 52 Zhang J, Yin Y, Wen Y, Shi F, Wang J. Anxiety and depression in patients with pulmonary arterial hypertension in Northwest China: a cross-sectional study. Front Psychiatry 2022; 12 (February): 758120
• 53 Mai AS, Lim OZH, Ho YJ. et al. Prevalence, risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis. Front Med (Lausanne) 2022; 9 (February): 765461
• 54 Rawlings GH, Beail N, Armstrong I, Thompson AR. Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial. ERJ Open Res 2022; 8 (01) 00526-2021
• 55 Chen SL, Zhang H, Xie DJ. et al. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study. Circ Cardiovasc Interv 2015; 8 (11) e002837
• 56 Rosenzweig EB, Ankola A, Krishnan U, Middlesworth W, Bacha E, Bacchetta M. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults. J Thorac Cardiovasc Surg 2021; 161 (04) 1438-1446.e2